Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib effect on hepatic CYP3A activity using midazolam phenotyping
NL-OMON22273Recruiting
- Sponsor
- Erasmus MC
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of lapatinib and midazolam, sponsored by Erasmus MC. Started Jan 2008; status: recruiting.
02
Drugs
lapatinibmidazolam
Beyond the preview
Go deeper on NL-OMON22273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22273.